We evaluated the clinical usefulness of assessing the ankle–brachial index (ABI) and carotid stenosis (CS) in a type 2 diabetic population. Patients with type 2 diabetes and coronary artery disease (n = 265) were enrolled in a prospective 3-year cohort study. The cardiovascular mortality rate was 8.7% (23 of 265) during the 36-month study and the all-cause mortality rate was 9.5% (25 of 265). Multivariate logistic regression analysis revealed that age (odds ratio [OR] 2.09), hypertension (OR 7.99), obesity (OR 4.86), internal CS (OR 262.17), and Gensini score (OR 1.15) were independent predictors of cardiovascular mortality. Mean ABI value (OR 0.15) was the only predictor of all-cause mortality in this population. The ABI and carotid artery ultrasound have independent prognostic value in a type 2 diabetic population.
BerryJKeeblerMEMcGuireDK. Diabetes mellitus and cardiovascular disease: Pandora’s box has been opened. Herz. 2004;29:456–462.
2.
SaydahSHFradkinJCowieCC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291(3):335–342.
3.
GrundySMHowardBSmithS. Diabetes and cardiovascular disease: AHA executive summary. Circulation. 2002;105(18):2231–2239.
4.
RydénLStandlEBartnikM; Task force members on diabetes and cardiovascular diseases of the ESC and EASD. Guidelines on diabetes, pre-diabetes, and cardiovascular disease. Eur Heart J. 2007;28(1):88–136.
5.
MorrishNJStevenLKHeadJ. A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO multinational study of vascular disease in diabetics). Diabetologia. 1990;33(9):542–548.
6.
BernardSSerusclarATargeF. Incremental predictive value of carotid ultrasonography in the assessment of coronary risk in a cohort of asymptomatic type 2 diabetic subjects. Diabetes Care. 2005:28(5):1158–1159.
7.
ParikhADanemanD. Is carotid ultrasound a useful tool in assessing cardiovascular disease in individuals with diabetes?Diabetes Technol Ther. 2004;6(1):65–69.
8.
IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care. Diabet Med. 2006;23(6):579–593.
9.
OzekeOArasDDeveciB. Comparison of presence and extent of coronary narrowing in patients with left bundle branch block without diabetes mellitus to patients with and without left bundle branch block but with diabetes mellitus. Am J Cardiol. 2006;97(6):857–859.
10.
HuGJousilahtiPQiaoQKatohSTuomilehtoJ. Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction. Diabetologia. 2005;48(5):856–861.
11.
PanzramG. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1987;30(3):123–131.
12.
LotufoPAGazianoJMChaeCU. Diabetes and all-cause and coronary heart disease mortality among US male physicians. Arch Intern Med. 2001;161(2):242–247.
13.
UusitupaMINiskanenLKSiitonenOVoutilainenEPyöräläK. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia. 1993;36(11):1175–1184.
14.
MiettinenHLehtoSSalomaaV. Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care. 1998;21(1):69–75.
15.
NorhammarATenerzANissonG. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002;359(9324):2140–2144.
16.
PanserLANaessensJMNobregaFTPalumboPJBallardDJ. Utilization trends and risk factors for hospitalization I diabetes mellitus. Mayo Clinic Proc. 1990;65(9):1171–1184.
17.
GoyderECSpiersNMcNallyPGDrucquerMBothaJL. Do diabetes clinic attendees stay out of hospital? A matched case control study. Diabet Med. 1999;16(8):687–691.
18.
BrunoGMereltiFBiggeriA. Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in Type 2 diabetes. Diabetes Care. 2004;27(11):2689–2694.
19.
LoweLPLiuKGreenlandPMetzgerBEDyerARStamlerJ. Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men. The Chicago Heart Association Detection Project in Industry Study. Diabetes Care. 1997;20(2):163–169.
20.
FullerJHStevensLKWangSL. Risk factors for cardiovascular mortality and morbidity: the WHO multinational study of vascular disease in diabetes. Diabetologia. 2001;44(suppl 2): S54–S64.
21.
CapesSHuntDMalmbergKGersteinH. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systemic review. Lancet. 2000;164:982–988.
22.
StrandersIDiamanatMvan GelderR. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med. 2004;164(9):982–988.
23.
BarsnessGWGershBJBrooksMMFryeRLF, for the Bari 2D Trial Investigators. Rationale for the Revascularization Arm of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2 D) Trial. Am J Cardiol. 2006;97(suppl 1):31G–40G.
24.
PyoralaMMiettinenHLaaksoMPyoralaK. Plasma insulin and all-cause, cardiovascular and non-cardiovascular mortality: the 22 year follow up results of the Helsinki Policemen Study. Diabetes Care. 2000;23(8):1097–1102.
25.
SkylerJSBergenstalRBonowRO. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care. 2009;32(1):187–192.
26.
HeldCHjemdahlPErikssonSVBjonkanderIForslundLRehnqvistN. Prognostic implications of intima-media thickness and plaque in the carotid and femoral arteries in patients with stable angina pectoris. Eur Heart J. 2001;22(1):62–72.
27.
BotsMLBladassarreDSimonA. Carotid intima-media thickness and coronary atherosclerosis: weak or strong relations?Eur Heart J. 2007;28(4):398–406.
28.
PetersSARuijterHMBotsMLMoonsKG. Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review. Heart. 2012;98(3):177–184.
29.
SerebruanyVLMalininAIPokovABarsnessGHanleyDF. Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: the PLavix Use for Treatment Of Diabetes (PLUTO-Diabetes) trial. Am Heart J. 2008;155:93.e1–e7.
30.
De BerardisGSaccoMEvangelistaV; for ACCEPT-D Study Group. Aspirin and simvastatin combination for cardiovascular events prevention trial in diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins. Trials. 2007;8:21.
31.
LorenzMWMarkusHSBotsMI. Prediction of clinical cardiovascular events with carotid intima-media thickness. Circulation. 2007;115(4):459-467.
32.
LeeEJKimHJBaeJM. Relevance of common carotid intima-media thickness and carotid plaque as risk factors for ischemic stroke in patients with type 2 diabetes mellitus. Am J Neuroradiol. 2007;28(5):916–919.
33.
SpenceJD. Ultrasound measurements of carotid plaques as a surrogate outcome for coronary artery disease. Am J Cardiol. 2002;89(suppl):10B–16B.
34.
GiralPBrucketEDaiorrouF. Usefulness in predicting coronary artery disease by ultrasonic evaluation of the carotid arteries in asymptomatic hypercholesterolemic patients with positive exercise stress test. Am J Cardiol. 1999;84(1):14–17.
35.
BosevskiMBorozanovVVavlukisMPemovskaGGeorgievska-IsmailLJ. Carotid ultrasound, blood lipids and waist determination can predict a future coronary revascularisation in the type 2 diabetic cohort. Prilozi. 2007;28(2):127–136.
36.
ParaskevasKIKotsikorisIKoupidisSAGiannoukasADMikhailidisDP. Ankle–brachial index: a marker of both peripheral arterial disease and systemic atherosclerosis as well as a predictor of vascular events. Angiology. 2010;61(6):521–523.
37.
BosevskiMKostoskaSTosevSBorozanovV. Prognostic importance of haemostatic parameters in polyarterial disease. Prilozi. 2005;26(1):81–92.
38.
CASS investigators. Long-term survival in patients with coronary artery disease: the importance of peripheral arterial disease. JACC.1994;23(5):1091–1095.
39.
NodariSManerbaAVaccariA. Six-year prognosis of diabetic patients with coronary artery disease. Eur J Clin Invest. 2011. doi: 10.1111/j.1365-2362.2011.02593.x
40.
NormanPEDavisWABruceDGDavisTM. Peripheral arterial disease and risk of cardiac death in type 2 diabetes. The Fremantile Diabetes study. Diabetes Care. 2006;29(3):575–580.
41.
MiharaTOohashiHHirataY. Mortality of Japanese diabetics in a seven-year follow-up study. Diabetes Res Clin Pract. 1986;2(3):139–144.
42.
LebsonCLRansomJEOlsenWZimertmanBRO’FallonWMPalumboPJ. Peripheral artery disease, diabetes and mortality. Diabetes Care. 2004;27(12):2843–2849.
